ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,630 | -24.6% | 805 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $28,706 | +40.4% | 805 | 0.0% | 0.00% | +50.0% |
Q1 2023 | $20,447 | -37.4% | 805 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $32,651 | +20.9% | 805 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $27,000 | -3.6% | 805 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $28,000 | -24.3% | 805 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $37,000 | -30.2% | 805 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $53,000 | -8.6% | 805 | -13.4% | 0.01% | -14.3% |
Q3 2021 | $58,000 | -24.7% | 930 | 0.0% | 0.01% | -36.4% |
Q2 2021 | $77,000 | -99.8% | 930 | +36.8% | 0.01% | +37.5% |
Q1 2021 | $45,091,000 | +86613.5% | 680 | 0.0% | 0.01% | -27.3% |
Q4 2020 | $52,000 | +79.3% | 680 | 0.0% | 0.01% | +37.5% |
Q3 2020 | $29,000 | 0.0% | 680 | 0.0% | 0.01% | -11.1% |
Q2 2020 | $29,000 | +45.0% | 680 | 0.0% | 0.01% | +28.6% |
Q1 2020 | $20,000 | -76.7% | 680 | -50.0% | 0.01% | -53.3% |
Q4 2019 | $86,000 | +352.6% | 1,360 | +100.0% | 0.02% | +150.0% |
Q3 2019 | $19,000 | -44.1% | 680 | -47.7% | 0.01% | -50.0% |
Q2 2019 | $34,000 | – | 1,299 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |